A good reminder of what we can accomplish when we stop to think about how we’ve treated ourselves over the years.
I’m no stranger to cancer, I’m just not in remission yet. The reason I’m not in remission is because I’ve had follicular lymphoma for about 5 years now. It’s a blood cancer which spreads through the lymphatic system in the body. It’s the most common type of cancer in men.
Its the second most common type of cancer in women. It often comes back after treatment, especially in the elderly. Although its more common in men, it’s the most common cancer in women.
As you can imagine it is very frustrating for any cancer patient to know that there are many types of cancer and that there can be many types of treatment for them. One of the reasons we decided to get involved with the fight against follicular lymphoma was because we wanted to ensure that there was something we could do to help this disease. We have already treated close to twenty patients (a few of which we are on the Honorary Board of Directors for) and are working on a few more.
This was our first time giving blood. I had a great experience, and it’s made me feel like I have a real stake in the fight against the disease.
The most impressive thing about this new movie trailer is that it is pretty much the only one that is coming in the next week. It really makes sense to jump right in and watch and enjoy the new trailer. There’s something really special about it.
In my opinion, this trailer is one of the best of the bunch, and it will be the best part of the trailer. I think that the plot of the film has come off the rails and really got us into this battle. The more we read about the new movie, the more people think about what it means to be in a fight against the disease.
I am glad to see that we are finally getting some good news for patients suffering from a common cancer. The Lymphoma Foundation of America (the one the film is based off of) recently announced that it has awarded a two-year, $25 million grant to the company that developed the new drug: Bortezomib. The $25 million grant is part of the “Cancer” series of grants awarded by the foundation.
The grant is for research and development of the drug Bortezomib, a drug that has been used only for four years in the fight against certain forms of lymphoma. It is the only new drug approved by the U.S. Food and Drug Administration for the treatment of some forms of the disease.
Bortezomib has been used in the treatment of a wide range of cancers, including mantle cell lymphoma, follicular lymphoma, and non-Hodgkin’s lymphoma. It’s also used to treat children with B-cell lymphoma, and is currently being tested in children with relapsed/refractory multiple myeloma.